TAI:4155
OK Biotech Co., Ltd. · TAI · Healthcare · TWD · FY for 2025
Figures on this page computed 2026-11-08 13:25 UTC
Last close
n/aTWD
Market data
30.9xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TWD
- computed
- Computed from the filing for 2025
3.1%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
5.3%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
-5.8%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
0.41Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TWD
- Computed from the filing for 2025
- Computed from the filing for 2025
1.5%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- TWD
- computed
Growth is the furthest below its sector's middle: 0.22 against 0.47 on the market's range.
Ten years as a story
lens 9 of 9We hold no filed year for this company, so there is nothing to read.
Nothing is drawn in its place. The other lenses are unaffected.